Aptose Presents Highlights From CG-806 KOL Event
December 12, 2018 10:00 ET
|
Aptose Biosciences, Inc.
SAN DIEGO and TORONTO, Dec. 12, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS) released highlights from a Key Opinion Leader (KOL) breakfast featuring a presentation by...
Aptose Enters Into License Agreement With CrystalGenomics to Acquire CG-806 Rights in China
June 14, 2018 07:05 ET
|
Aptose Biosciences, Inc.; CrystalGenomics, Inc.
SAN DIEGO and SEOUL, South Korea, June 14, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS) today announced that they have entered into a license agreement with...